Abstract
Therapy-related leukemia associated with chemotherapy, particularly alkylating agents and topoisomerase II inhibitors, are being reported with increasing frequency in the literature mainly after breast cancer. We also observed an increasing number of such leukemias in the data base of the specialized registry of hematological malignancies of the Côte d'Or department. Between 1980 and 1998, 156 AML and RAEB-t were registered in women in Côte d'Or. Among them, 12 occurred in women with breast cancer history (7.7%). Analysis by period of time shows a significant increase in the proportion of therapy-related leukemia secondary to breast cancer (P < 0.02). chemotherapy including topoisomerase ii inhibitors was used in 10 cases in which mitoxantrone was used in eight cases. in these eight cases, leukemia had clinical and biological characteristics usually described with topoisomerase ii inhibitors but 44% were promyelocytic sub-type with the t(15;17) specific karyotypic abnormality. these data on a well-defined population demonstrate the increased proportion of therapy-related leukemia secondary to breast cancer, probably due to the use of mitoxantrone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Whitlock JA, Greer JP, Lukens JN . Epipodophyllotoxin-relatedleukemia. Identification of a new subset of secondary leukemia Cancer 1991 68: 600–604
Pedersen Bjergaard J, Specht L, Larsen SO, Ersbil J, Struck J, Hansen MM, Hanse HH, Nissen NI . Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy Lancet 1987 2: 83–88
Curtis RE, Boice JD Jr, Moloney WC, Ries LG, Flannery JT . Leukemia following chemotherapy for breast cancer Cancer Res 1990 50: 2741–2746
Thirman MJ, Larson RA . Therapy-related myeloid leukemia Hematol Oncol Clin North Am 1996 10: 293–320
Bahtia MJ, Davies SM, Robinson LL . Leukemia. In: Neugut AI, Meadows AT, Robinson E (eds) Multiple Primary Cancers Lippincott Williams & Williams: New York 1999 257–276
Laughlin MJ, McGaughey DS, Crews JR, Chao NJ, Rizzieri D, Ross D, Gockerman J, Cirrincione C, Berry D, Mills L, Defusco P, Legrand S, Peters WP, Vredenburg JJ . Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 1998 16: 1008–1012
Kumpulainen EJ, Hirvikoski PP, Pukkala E, Johansson RT . Cancer risk after adjuvant chemo- or chemohormonal therapy of breast cancer Anticancer Drugs 1998 9: 131–134
Linassier C, Barin C, Bremond JL . Secondary leukaemia in breast cancer patients after exposure to an association of mitoxantrone, fluorouracil, cyclophosphamide and radiotherapy Proc Am Soc Clin Oncol 1996 15: 360–363
Pedersen Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen O, Mouridsen H, Dombernowsky P . Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer J Clin Oncol 1992 10: 1444–1451
Carli PM, Milan C, Lange A, Devilliers E, Guy H, Faivre J . Haematopoietic malignancies in Côte d'Or (France): a population based study Br J Cancer 1986 53: 811–815
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield C . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997 J Clin Oncol 1999 17: 3835–3849
Mitelman F, Kargers S, Basel P . An International System for Human Cytogenetic Nomenclature ISCN 1995
Smith MA, Rubinstein L, Ungerleider RS . Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Med Ped Oncol 1994 23: 86–98
Dissing M, Le Beau MM, Pedersen Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? J Clin Oncol 1998 16: 1890–1896
Hoffmann L, Mö P, Pedersen Bjergaard J, Waage A, Pedersen M, Hirsch FR . Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature Ann Oncol 1995 6: 781–788
Detourmignies L, Castaigne S, Stoppa AM, Harousseau JL, Sadoun A, Janvier M, Demory JL, Sanz M, Berger R, Bauters F . Therapy-related acute promyelocytic leukemia: a report on 16 cases J Clin Oncol 1992 10: 1430–1435
Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flamery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN . Risk of leukemia after chemotherapy and radiation treatment for breast cancer New Engl J Med 1992 326: 1745–1751
Ellis M, Ravid M, Lishner M . A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias Leuk Lymphoma 1993 11: 9–13
Acknowledgements
We thank Dr M Flesch and Dr F Bailly for their contributions to the Registre des Hémopathies Malignes de la Côte d'Or.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carli, P., Sgro, C., Parchin-Geneste, N. et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 14, 1014–1017 (2000). https://doi.org/10.1038/sj.leu.2401787
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401787
Keywords
This article is cited by
-
Exploiting senescence for the treatment of cancer
Nature Reviews Cancer (2022)
-
Mitoxantron-assoziierte akute Leukämie bei Multipler Sklerose
Der Nervenarzt (2010)
-
Molecular biology of therapy-related leukaemias
Clinical and Translational Oncology (2010)
-
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia
Leukemia (2006)
-
Incidences and Trends of Second Cancers in Female Breast Cancer Patients: A Fixed Inception Cohort-based Analysis (United States)
Cancer Causes & Control (2006)